Xyratex (XRTX $9.55 -0.71) reported second quarter at ($0.06) per
share, excluding non-recurring items, $0.04 worse than the Capital IQ Consensus
Estimate of ($0.02).
Revenues fell 25.8% year/year to $338.5 million versus the $338.7 million
consensus.
For the third quarter, the company expects to see earnings of $0.10 to $0.28,
excluding non-recurring items, versus the $0.22 Capital IQ Consensus Estimate
and expects revenue to fall in the range of $336 million to $376 million versus
the $345.46 million Capital IQ Consensus Estimate.






